TY - JOUR A2 - Magi-Galluzzi, Cristina AU - Manneh, Ray AU - Brugés, Ricardo AU - Correa, Jose Jaime AU - Rojas, Julián AU - Rojas, Daniel AU - Villareal, Nicolás PY - 2021 DA - 2021/11/09 TI - Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America SP - 3334333 VL - 2021 AB - Most prostate cancer patients who undergo androgen-deprivation therapy or orchiectomy will eventually develop castration-resistant prostate cancer (CRPC), often preceded by a nonmetastatic CRPC state known as M0CRPC.近代二代抗安卓为临床医生提供M0CRPC有效安全处理然而,这些病人的复杂程度通常需要处理基本余症和聚用药类问题,他们往往挑战这一环境的治疗决策。最新开发新图像技术也为临床医生提供工具检测敏感度和特性高的适应然而,由于缺乏早期检测损耗和对治疗决策的相应影响的证据,这些技术成为双刃剑,必须适当管理介绍专家快速进化M0CRPC概念并提出建议辨识这些病人,适当使用新成像模式和病人管理,特别是考虑到他们的临床复杂性和下一代抗原最近开发SN-2090-3111UR-https://doi.org/101155/2021/33333DO-10.1155/2021/33133JF-前列腺癌PB-HindawiKW-ER